Stay updated with breaking news from Teva Pharms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Case Name: Vanda Pharms. Inc. v. Teva Pharms. USA, Inc., Nos. 22-7528, 22-7529 (CCC), 2023 WL 1883357 (D.N.J. Feb. 10, 2023) (Cecchi, J.) - Drug Products and...
After the Supreme Court invited the Solicitor General to file a brief expressing the views of the United States regarding Teva Pharms USA, Inc. v. GlaxoSmithKline LLC, et al., the...
Ironburg Inventions Ltd. v. Valve Corp., Appeal Nos. 2021-2296, 2021-2297, 2022-1070 (Fed. Cir. April 3, 2023) In this week’s Case of the Week, the Federal Circuit...
On October 3, 2022, the U.S. Supreme Court invited the Solicitor General to weigh in with the views of the United States on the U.S. Court of Appeals…
The Supreme Court invited the Solicitor General to weigh in on the Court of Appeals for the Federal Circuit’s decision in GlaxoSmithKline v. Teva Pharms. The Solicitor General’s brief took the position that the Supreme Court should grant Teva’s petition for a writ of certiorari.